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Abstract
In professional road cyclists, the majority of overuse injuries affect the lower limbs and are mostly represented by contractures or
muscle shortening, characterized by an increase of tone and stiffness and a variation of elasticity. Treatment and prevention of these
speciﬁc conditions may include physical, supplementary, and pharmacologic support. The aim of this real-life study was to
determine: ﬁrst, the alterations of tone, stiffness, elasticity, and soreness of rectus femoris (RF) and biceps femoris (BF) in top class
cyclists engaged in 3multistage races, and second, whether any variable in themanagement of the athletesmay affect the prevention
and/or reduction of such alterations.
Twenty-three professional cyclists competing in 3 international, cycling stage races were assessed. Athletes could receive, upon
the approval of the medical staff, physical, dietary, and/or pharmacological management which could include treatments with topical
over-the-counter myorelaxants to prevent and/or reducemuscle contractures. MyotonPro was used to daily measure tone, stiffness,
and elasticity in RF and BF in relaxed and contracted state after every stage. In parallel, BF and RF soreness was also assessed with a
Likert scale.
All athletes received the same general massage management; none of them received dietary supplements; some of the athletes
were treated with a topical myorelaxant thiocolchicoside (TCC 0.25%) foam 3 times daily. TCCwas identiﬁed as the only variable able
to affect these muscle parameters in the cyclists. Tone, stiffness (regardless of the state), and soreness signiﬁcantly increased over
time either in BF or RF in all athletes. In the group of athletes that used TCC (n=11; TCC+) the increase in tone, stiffness, and
soreness was signiﬁcantly lower than in the group not receiving TCC (n=12; No-TCC). Elasticity varied coherently with tone and
stiffness.
A very intense and protracted sport activity increases muscular tone, stiffness, and soreness over time. Topical TCC foam
signiﬁcantly attenuates these alterations and might represent an efﬁcient strategy both to prevent and manage contractures and their
consequences in professional cyclists as well in athletes from other disciplines involving similar workloads.
Abbreviations: AU = arbitrary units, BF = biceps femoris, FFM = free fat mass, FM = fat mass, GABA = g-aminobutyric acid,
MMA = mixed model analysis, RF = rectus femoris, TCC = thiocolchicoside.
Keywords: contracture, elasticity, stiffness, thiocolchicoside, tone, top class road cyclists
1. Introduction
During training and competitions, cyclists are subjected to both
traumatic and overuse injuries: in particular, the incidence of
overuse injuries in recreational cyclists over a 1-year period may
be higher than 85%.[1,2] A history of sport-related overuse
injuries to inferior limb is present in 42% to 65% recreational
cyclists.[2,3] Even in the professional cyclists, overuse injuries are
more frequent in the lower extremities.[4] Indeed, De Bernardo
et al[4] found that 51.5% of total injuries in top-level professional
road cyclists are represented by overuse conditions and that,
among them, 67.7% afﬂict lower limbs; 26.4% of these lower
limbs injuries are represented by hamstrings and quadriceps
contractures. Muscle contracture is an involuntary, painful, and
persistent contraction of 1 or more skeletal muscles, which
represents a defensive action occurring when the muscle is
stressed beyond its physiological tolerance.[5]
The evaluation of the contraction state, be it basal or not, of a
given muscle can be achieved measuring speciﬁc mechanical
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parameters reﬂecting its viscoelastic properties, namely muscle
tone and stiffness.[6–8]
According to De Bernardo et al[4], elite road cyclists showed a
high number of muscle “contractures” presumably due to
repetitive eccentric and concentric exercise. “Contractures” are
therefore considered to be overuse injuries and the incidence of
these types of lesions deserves more attention and should be
mentioned in sports injury surveillances.[4] The patient feels an
involuntary increase in muscle tone and lack of muscle elasticity
during movements.[5,9] Moreover, contracted muscles show
increased stiffness, an effect which may cause the onset of more
severe damages and pain, particularly after intense training.[10,11]
Since it is difﬁcult to address or anticipate an injury in
professional sportsman, any strategy to enhance injury preven-
tion represents a sensitive issue in sport medicine. To our best
knowledge, very few studies focused on the treatment and
prevention of these speciﬁc conditions that may include physical,
supplementary, and pharmacological support, such as body
massage, dietary supplement, and myorelaxant agents.
Thiocolchicoside (TCC) is a semisynthetic sulfur derivative of
naturally occurring colchicoside from the seeds of Gloriosa
superba and Colchicum autumnale. TCC has established muscle-
relaxant, anti-inﬂammatory, and antalgic properties,[12] and it
has been shown to inhibit the binding of [3H] GABA (g-amino-
butyric acid) or [3H]strychnine to rat cerebrocortical or spinal
cord membranes in vitro and in vivo.[13–15] However, TCC
molecular targets and mechanisms of action are not yet
completely understood.
TCC is clinically used since more than 45 years for the
treatment of muscle pain and contractures in patients with
orthopedic, rheumatologic, or musculoskeletal disorders.[12] Its
effectiveness in these conditions, particularly in low-back pain,
has been shown by several clinical studies[16–19] where TCC had
been administered orally, parenterally, and topically. TCC
transdermal delivery, which has been studied by Artusi
et al[20], has the advantage of avoiding systemic side effects
and improving patient compliance. In the form of nongreasy
topical foams or gels, particularly when associated to skin
penetration enhancers,[21,22] TCC may represent a well tolerated
and effective formulation for the treatment and prevention of
muscle contractures.
The aim of this observational ﬁeld study was ﬁrst, to determine
the alterations of tone, stiffness, elasticity, and the level of pain
(muscle soreness) of rectus femoris (RF) and biceps femoris (BF)
in top class cyclists engaged in 3 multistage races, over a period of
1 week per each race; second, to determine whether routine
topical TCC administration or any other variable in the
management of the athletes, may prevent or reduce the entity
of such alterations.
2. Methods
2.1. General and pharmacological management of the
athletes
This is a prospective, observational study carried out in a ﬁeld
setting on 23 top-level cyclists from one of the 17 professional
UCI World Tour teams which competed in 3 cycling stage races
(Tour de Pologne, Eneco, and Vuelta a España). The protocol of
the study has been approved by the Local Ethics Review
Committee on May 23, 2015.
Cyclists’ weight and height were measured at the ﬁrst day of
each tour (Pologne, Eneco, and Vuelta a España) and body mass
indexwas calculated; fat mass (FM) and free FM (FFM)were also
determined by impedentiometry (Akern BIA 101, Akern Srl,
Florence, Italy).
During the competition, all athletes received generic total body
massage (every day after each race), according to the standard
procedures adopted by the medical staff of the team. In addition
to these routine procedures, some athletes received topical
treatment with TCC according to the indication of the medical
staff. In these athletes (TCC+ group), TCC treatments were
performed with a foam containing TCC (Miotens foam, Dompé
Farmaceutici S.p.a., Milan, Italy. Miotens foam contains 0.25%
TCC; eccipients: Polysorbate 80, propylene glycol, ethyl alcohol,
propylene glycol, propylene glycol dipelargonate, benzyl alcohol,
sodium mono, and diphosphate, Nerolene lavender, water).
For each of the 3 races, TCC was administered 3 times daily
and concomitantly with generic massages (morning prerace,
postrace, and postdinner) for 7 days. The amount of foam, about
3/5mL per muscle group, could slightly vary depending on the
extension of the treated area (RF or BF).
No additional pharmacological treatments or supplementary
procedures were performed to the athletes in the course of the
present study; all the procedures were performed as in routine
professional practice and athletes were observed for the entire
duration of the study.
During 1-week period for every race the athletes included in the
study were evaluated using the Myoton technology (Myoton AS,
Tallinn, Estonia) (see below), in order to determine the alterations
of muscle tone, stiffness, elasticity, and soreness.
After every race stage (before the dinner) participantswere asked
to lie in a supine position on a massage table to assess RF, and in a
prone position to assess BF. All the assessments were made on the
subject’s dominant limb in relaxed and isometric contraction state.
The entire assessment was carried out by an expert in the use of
Myoton technology. For the RF measurement (relaxed state), the
subject extendedhis kneekeeping thehip in aneutral position,with
sandbags placed on either side of the ankle to maintain this
position. Measurements were taken at 2/3 of the distance between
the anterior superior iliac spine and the superior pole of the patella,
to locate a reproducible site over themuscle belly.[23] The isometric
condition of RF was evoked by a hip ﬂexion of 45° and the
measurements were carried out by asking the subject to maintain
this position. Finally, for the BFmeasurement, the subject assumed
a prone position with his knee extended and hip in a neutral
position. The point ofmeasurementwas identiﬁed after the subject
ﬂexedhis leg to a 45° angle from the horizontal position, producing
a slight isometric contraction of the muscle in order to identify the
center of themuscle belly. As in the case of RF, tomeasure the state
of BF isometric contraction subjects were asked tomaintain the leg
ﬂexed at an angle of 45°.[24]
2.2. Determination of the best 30-minute power outputs
The best 30-minute power outputs were obtained from the SRM
Powermeter (SRM, Julich, Germany) records taken during the
3 races.
2.3. Measurements of mechanical properties
Muscle mechanical properties were determined using Myoton
technology, an in vivo, noninvasive device capable of measuring
the state of tension (non-neural tone) and mechanical properties
of individual skeletal muscles, with the advantage of portability
and relatively low cost. The device provides objective
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measurements of 3 mechanical properties of muscles: tone,
stiffness, and elasticity,[7] parameters which signiﬁcantly vary
according to the degree of the contracture state of the muscle.
The measurements were made positioning the MyotonPro
probe, preloaded at 0.18N, perpendicularly to the skin over the
muscle being assessed, with a precompression of the subcutane-
ous tissues performed independently of the assessor. The device
applied brief (15ms) low force (0.4N) mechanical impulses,
inducing damped natural oscillations of the underlying tissues.
These oscillations were recorded by an accelerometer connected
to a friction measurement mechanism in the device. The device
then simultaneously calculated the resting tone parameters
(frequency of oscillation [Hz]), elasticity of weak oscillations
(logarithmic decrement [arbitrary units (AU)], and stiffness [N/
m]). Considering the high intraclass correlation coefﬁcients found
between 2 10-impulse measurements carried out in the
Agyapong-Badu et al[25] study, it was decided that a single 10-
impulse measurement was adequate.
2.4. Parameters measured
The resting tone, deﬁned as the maximum frequency (F= fmax)
computed from the signal spectrum by fast Fourier transform,
was recorded (frequency [Hz]). The higher the frequency of the
oscillations (natural oscillation frequency), the greater the muscle
tension, which increases with contractions and stretching.[26]
Stiffness (N/m) is the measurement of the muscle’s ability to
resist an external force that modiﬁes its shape[27] and is calculated
using the formula:
S ¼ mprobe amax
Dl
 
The higher the N/m value is, the greater the muscle stiffness.
Elasticity describes the ability of the tissue to recover its
original shape after being deformed. Elasticity can be described
with a logarithmic decrement, which shows the dampening of the
oscillation, that is, the dissipation of mechanical energy in the
tissue in the course of an oscillation cycle. The lower the
decrement value is, the smaller the consequent dissipation of
mechanical energy, and therefore the greater the elasticity.
Elasticity is expressed in AU and represents the logarithm of the
dissipation in the tissue during a single oscillation period (log D),
calculated as reported elsewhere.[24,25]
2.5. Muscle soreness
Before the daily determinations of mechanical properties, the
level of muscle soreness was assessed using a Likert scale ranging
from 0 to 6 (0=no soreness; 1=dull feeling of soreness; 2= light,
continuous soreness; 3=more than light soreness; 4=annoying
soreness; 5= severe soreness; 6= intolerable soreness); it was also
permitted to report an intermediate value (e.g., 2.5), if
necessary.[28] The investigator palpated the medial part of the
BF and RF by applying pressure with the tip of 3 ﬁngers (II, III,
and IV) for approximately 3 seconds.[29] The participants were
instructed to report pain sensation experienced during the
palpation. The same investigator assessed the muscle soreness of
all participants over race days.
2.6. Statistical analysis
Descriptive analyses were performed considering mean standard
deviation (SD) variation of tone, elasticity, and stiffness along the
race days, for both RF and BF, either in contracted or relaxed
conditions.
These descriptive analyses were performed both in the overall
group of athletes and in subgroups where differences in the
management were identiﬁed, namely the athletes that used or not
the Miotens foam (TCC+ and No-TCC, respectively). Indepen-
dent Student t test analysis was performed to determine whether
these subgroups were homogeneous in terms of age, height,
weight FM, and FFM.
Mixed model analysis (MMA) was used for statistical analysis.
Dependent variables were tone, elasticity, and stiffness measured
using MyotonPro device. All independent variables were
considered as ﬁxed effects. In MMA, 4 principal effects and all
two-way interactions were considered. MMA was also used for
analyzing soreness data in both BF and RF: the day of race and
TCC treatment were taken as predictive factors. All elaborations
were conducted with a=0.05. Elaborations and graphics were
obtained using Excel (Microsoft) and SPSS version 20.0 (SPSS
Inc., Chicago, IL).
3. Results
A total of 23 athletes participating to the 3 races were included
and evaluated in this real-life study, as described in Table 1.
During these races, the recorded maximal mean power for a 30-
minute period was 397.6±24W or 5.4±0.4W/kg (average±
SD): this value is in keeping with those previously recorded
during Tour de France mountain stages[30] and indicates that our
subjects can be considered as top level cyclists. All athletes
included received the same general massage management. In
addition, some of the athletes (TCC+, n=11) were treated with
the topical myorelaxant agent TCC, which is widely used among
sport practictioners, while 12 subjects did not receive it (No-
TCC). TCC was contained in a nonoil foam (Miotens, with
0.25% of TCC, Dompé Farmaceutici S.p.a.) administered 3 times
daily (morning prerace, postrace, and postdinner) for 7 days/race
(i.e., the entire duration of Tour de Pologne and Eneco Tour and
the ﬁrst week of race for La Vuelta). The amount of foam was
about 3 to 5mL per muscle group and could slightly vary
depending on the extension of the treated area (RF or BF).
No additional physical, pharmacological, or dietary supple-
ment treatments were performed to the athletes in the present
real-life study.
Therefore, study parameters were analyzed both in the general
population included in the study and in the 2 groups of athletes
receiving or not TCC (i.e., the only additional variable which has
been identiﬁed among athletes) in order to assess if TCC may
demonstrate any effect on muscle parameters.
Tables 2 and 3 show the baseline characteristics of the included
athletes.
As shown in Table 3, there was no signiﬁcant difference
between the major baseline anthropometric parameters of the
included athletes.
Table 1
Athletes enrolled in the study.
Tour Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Pologne 8 8 8 8 7 6 6
Eneco 8 8 8 8 8 8 8
Vuelta 7 7 7 7 7 7 7
Total 23 23 23 23 22 21 21
Dropouts were due to team strategies (1) and a knee pain recrudescence.
Gervasi et al. Medicine (2017) 96:30 www.md-journal.com
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Figures 1, 3, and 4A–D show tone, stiffness, and elasticity
values, respectively, in RF and BF as a function of race days in
both No-TCC and TCC+ subgroups, either in the contracted (A
and C) and relaxed state (B and D).
3.1. Tone
Results, analyzed according to MMA, demonstrated that muscle
tone increased signiﬁcantly (P= .046) in a time-related fashion,
i.e., day-by-day over the races in all the conditions tested and
considered (TCC+ and No-TCC, BF and RF, contracted and
relaxed state, refer to Fig. 1A–D); the values ranged from an
initial value of 16.75±2.83Hz (the mean of the ﬁrst determi-
nations in each race), to a ﬁnal value of 17.82±3.32Hz (the
mean of the last determinations in each race), with a 6.0%
increase.
A 27.46% variation (P< .001) of tone (BF and RF pooled
values) as measured in the contracted (19.62±3.33Hz) versus
relaxed state (15.39±1.47Hz) was found: such a difference is in
accordance with previous reports.[24]
With regard to the effects observed in TCC+ group,
interestingly, a lower increase of tone (P= .012) was found, as
compared to No-TCC subjects (Fig. 1A–D). A detailed
comparison between the tone values of TCC+ and No-TCC
groups is also given in Table 4.
Furthermore, the effect observed in TCC+ as compared to No-
TCC group on muscle tone was unrelated to time, that is, race
Figure 1. Rectus and biceps femoris tone (Hz) in contracted (A and C) or relaxed (B and D) state as a function of time (race days). Open and closed symbols refer to
No-thiocolchicoside (TCC) and TCC+, respectively. Each point represents the mean of the values obtained in days 1 to 7 of the 3 races detailed in the “Methods”
section in the 2 groups (No-TCC n=12; TCC+ n=11). Bars represent standard errors.
Table 2
Anthropometric description of the enrolled athletes (mean±SD).
Variables Mean±SD (n=23) Min–max
Age 29.3±4.8 22–38
Weight, kg 75.4±8.4 62–93
Height, cm 182.7±4.8 174–190
FM% 12.6±4.4 5–23.6
FFM% 62.9±5.2 52.2–75.7
BMI 22.5±1.8 18.8–26.1
BMI = body mass index, FFM% = free fat mass, FM% = fat mass, TCC = thiocolchicoside.
Table 3
Anthropometric parameters of athletes from No-TCC or TCC+
groups.
Variables No-TCC (n=12) TCC+ (n=11) t (P)
Age 27.8±4 29±4.9 0.62 (.54)
Weight, kg 77.1±8 73.9±9.1 0.86 (.40)
Height, cm 183.3±4.6 182.6±5.1 0.33 (.74)
FM% 13.4±5.3 11.7±3.4 0.86 (.40)
FFM% 63.7±3.8 62.1±6.6 0.69 (.50)
BMI 22.9±1.6 22.1±2.1 0.99 (.33)
BMI = body mass index, FFM% = free fat mass, FM% = fat mass, t = test t value, TCC =
thiocolchicoside.
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days (P= .59), muscle type (P= .74), and state (P= .97),
suggesting that TCC was equally active in RF and BF in both
states and in every race day.
The effect of topical TCC treatment can be better appreciated
in Fig. 2A and C, showing the percent differences between the
tone values (obtained pooling the relaxed and contracted state
values) of BF and RF at the beginning and at the end of the races
in No-TCC (RF 9.2%; BF 9.9%) versus TCC+ (RF 1.1%; BF
7.9%) groups: smaller differences invariably characterized the
TCC+ group.
3.2. Stiffness
Similarly to the tone, muscle stiffness (Fig. 3A–D) increased
signiﬁcantly (P= .014) in a time-related fashion, that is, day-by-
day over the races in both TCC+ and No-TCC groups; this effect
was independent of muscle type and state. Muscle stiffness (BF
and RF in both states pooled values) ranged from an initial value
of 305.3±84.8N/m to a ﬁnal value of 337.1±99.1N/m, with a
10.5% increase.
Not surprisingly,[24] relaxed state stiffness (BF and RF pooled
values) was 265.9±32.4N/m as compared to 391.2±103.0N/m
in the contracted state, with a +47.1% variation (P< .001).
Again, similarly to tone, a signiﬁcantly lower increase of
stiffness (P= .028) was observed in TCC+ athletes and in all the
conditions tested, as compared to No-TCC subjects (Fig. 3A–D
and Table 4).
The effect of TCC can be also appreciated in Fig. 2B and D,
which illustrates the percent differences between the stiffness
values (BF and RF in both states) at the beginning and the end of
the races in No-TCC (RF 18.6%; BF 14.1%) versus TCC+ (RF
0.6%; BF 10.8%): lower differences characterized the latter
group.
3.3. Elasticity
The elasticity changed quasi-signiﬁcantly over time (P= .057), in
all the conditions tested (Fig. 4A–D); the values (BF and RF in
both states pooled values) ranged from 1.37±0.30 at the
beginning of the races to 1.31±0.27 AU at the end with a 4.3%
variation.
According to data in literature,[24] elasticity signiﬁcantly
(P< .001) varied when scored in relaxed or contracted states:
AU values were 1.14±0.24 and 1.52±0.22 in the contracted and
relaxed state, respectively, with a 24.71% difference.
As to TCC treatment, it did not signiﬁcantly affect elasticity
(P= .362); No-TCC subjects showed a mean AU of 1.32±0.29 as
compared to 1.34±0.30 in TCC+ group, with a variation of
1.7% (Table 4; Fig. 4A–D).
3.4. Muscle soreness
As it could be expected, the results showed a signiﬁcant increase
of muscle soreness (P< .001) over time in both groups, in
either BF or RF (Fig. 5). Notably, TCC+ athletes exhibited a
signiﬁcantly lower increase in muscle soreness (P< .001) in both
BF and RF as compared to No-TCC subjects: BF and RF values in
No-TCC were 2.35±1.26 and 2.74±1.31, as compared to 1.87
Table 4
Effects of TCC: comparison between No-TCC and TCC+.
Variables No-TCC TCC+ Effect of TCC, % P
Tone, Hz 17.75±3.21 17.25±3.43 2.9 .009
Stiffness, N/m 334.5±93.9 322.5±103.3 3.6 .028
Elasticity, log D 1.32±0.29 1.34±0.31 1.7 .362
No-TCC: mean±SD of No-TCC values irrespectively to race day, muscle type, and muscle state. TCC
+: mean±SD of TCC+ values irrespectively to race day, muscle type, and muscle state. Effect of TCC
(%): global percent variation between No-TCC and TCC+. TCC = thiocolchicoside.
Figure 2. Percent differences between days 1 and 7 (beginning and end of the races) values of tone (A and C) and stiffness (B and D) in No-thiocolchicoside (TCC)
(open bars) and TCC+ (solid bars) groups in RF (A and B) and BF (C and D). Percent differences have been calculated using the values obtained pooling the data
recorded in the contracted and relaxed states.
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±1.36 and 2.26±1.26 in TCC+ group, respectively (Fig. 5A
and B).
4. Discussion
It is well known that muscle tone and stiffness are the expression
of 2 separate components, a neural 1 depending on central
nervous system activity and a non-neural, known as myofascial
or viscoelastic, component depending on the thixotropic state of
the myofascial tissue.
The notion of neural tone, or reﬂex tone, was derived from
experiments on decerebrate animals, which showed markedly
exaggerated stretch reﬂexes. Therefore, the extent of the neural
component depends on the intensity of the central nervous system
stimuli acting on muscles and is invariably associated with a
corresponding, proportional electromyographic activity.
By contrast, the viscoelastic tone of myofascial tissue is not
associated with muscle electrical activity, and indeed it cannot
be detected with needle or surface electromyography. The
viscoelastic tone can be measured exclusively when the muscle is
in relaxed state. Moreover, the viscoelastic properties of
muscle tissue are not constant, but depend upon previous
movements: these movement-dependent changes of the visco-
elastic tone are a typical expression of the thixotropic nature of
muscles.[31]
Data herein presented show that in top-level cyclists tone and
stiffness increase as a function of time over the race and that this
increase is independent of the state of the muscles (relaxed or
contracted) as well as of the type of muscle (RF or BF). Hence,
strenuous physical activity causes a prompt increase of both tone
and stiffness either in resting, passive conditions, or in isometric
voluntary contraction ones.
To our best knowledge, this is the ﬁrst study carried out in a
real-life setting directly dealing with the effects of strenuous,
protracted, and repeated physical activity on muscle tone
and stiffness in elite cyclists in the course of world tour
competitions, demonstrating a time-related, signiﬁcant increase
of these 2 parameters. Although more studies are required in this
area, it is conceivable that the increase of tone and stiffness
reported herein depends, at least, on 2 different causes, namely
(ﬁrst) chronic muscle overload and (second) psychological
distress.
First, chronic muscle overload is known to emerge as a
consequence of sustained contraction and repetitive activity
usually characterizing the strenuous physical activity required by
speciﬁc sport disciplines. This muscle condition is thought to be
involved in the increased tension and stiffness of myofascial
tissue[32]; although this increase is poorly documented in the
scientiﬁc literature, some authors argue that during exercise the
calcium ions accumulating in the sarcoplasm of the muscle cell
contribute to muscle contractures (see also below). Accordingly,
these contractures may be relieved by rest.[32,33]
Second, according to some studies, muscle tone is also affected
by the so-called unnecessary muscle tension or extraneous muscle
tension.[31] Unnecessary muscle tension is thought to depend also
on the psychological distress normally associated with increased
Figure 3. Rectus and biceps femoris stiffness (N/m) in contracted (A and C) and relaxed (B and D) state as a function of time (race days). Open and closed symbols
refer to No-thiocolchicoside (TCC) and TCC+, respectively. Each point represents the mean of the values obtained in days 1 to 7 of the 3 races detailed in the
“Methods” section in the 2 groups (No-TCC n=12; TCC+ n=11). Bars represent standard errors.
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muscular activity: indeed, according to a recent critical review,
there is a direct relationship between excessive worry, mental
distress/cognitive load and muscle tension.[34]
Both these causes are likely to contribute to the tone and
stiffness increase observed in our experimental groups, which are
formed by professional elite cyclists participating to a top-level
competition.
The third parameter examined, namely muscle elasticity (i.e.,
the ability of the tissue to recover its original shape after being
deformed) did not change signiﬁcantly over time. However a
quasi-signiﬁcant tendency toward increased elasticity was
observed, an effect which is the plausible expression of the tone
and stiffness variations described above.
Aside from the goal of the present research, it is worth noting
that we found a generally higher variability of the above
parameters when determined in the contracted as compared to
the relaxed state; this observation has also been reported in other
studies, such as that by Gavronski et al.[24]
Another interesting ﬁnding of this study is that we observed for
the ﬁrst time that topical administration of TCC foam during the
races signiﬁcantly reduces the time-related increase of muscle
tone and stiffness.
Figure 5. Rectus and biceps femoris soreness as a function of time (race days). Open and closed symbols refer to No-thiocolchicoside (TCC) and TCC+,
respectively. Each point represents the mean of the values obtained from days 1 to 7 of the 3 races detailed in the “Methods” section in the 2 groups (No-TCC n=
12; TCC+ n=11). Bars represent standard errors.
Figure 4. Rectus and biceps femoris elasticity (Ln D) in contracted (A and C) and relaxed (B and D) state as a function of time (race days). Open and closed symbols
refer to No-thiocolchicoside (TCC) and TCC+, respectively. Each point represents the mean of the values obtained in days 1 to 7 of the 3 races detailed in the
“Methods” section in the 2 groups (No-TCC n=12; TCC+ n=11). Bars represent standard errors.
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This effect is in line with the locally acting myorelaxant
properties of TCC observed by Janbroers[12] in isolated animal
muscle preparations or by Ketenci et al[35] in the treatment of
acute cervical myofascial pain syndrome. To this regard, since in
our study TCC was effective through the transdermal route, it
is unlikely that its activity derives from the interactions
with central neural pathways, such as glycinergic or
GABAergic paths[13,36] as well from a reduction of psychological
distress. Rather, TCC effect is more likely dependent on direct
actions on the myofascial tissue: these actions are not limited
to myorelaxation, but probably include TCC anti-inﬂammatory
and antalgic activities.[12] Accordingly, a lower and signiﬁcant,
time-related increase in muscle soreness was observed in TCC+
group as compared to No-TCC. To this regard it is important
considering that inﬂammation and soreness deriving from
particularly stressing muscle utilization, that is, the same
situations of the athletes studied herein, are known to result
in muscle spasm and contractures.[35,37] Hence TCC is likely
to act through multiple mechanisms converging toward the
prevention of muscle contractures and their symptoms. In this
light, TCC is likely to act in a pleiotropic fashion, a very
common mode of action among plant-derived bioactive
substances.[38]
It is also important to point out that our results have been
obtained in a unique situation, that is, a group of 23 top-level,
international professional cyclists monitored in the course of a
strenuous international championship such as the World Tour
Competition. The capacity of TCC, administered topically as
foam, to mitigate the increase of tone and stiffness in such an
exceptional situation is of particular interest and relevance from
the sport medicine point of view. Indeed, reduction of tone and
stiffness corresponds to a lesser susceptibility to muscle
contractures. In particular, this innovative foam formulation
(Miotens), containing propylene glycol and propylene glycol
diperlargonate as skin penetration enhancers, has been found to
signiﬁcantly promote TCC accumulation into full human skin
thickness in comparison with the simple drug solution[21] and
with other commercial TCC-based products.[22]
As discussed above, contractures result from overuse-related
reversible shortening of the muscle and lead to the so-called
delayed-onset muscle soreness. This clinical condition has been
related to microscopic muscle ﬁber damage induced mainly by
repeated eccentric muscle contractions. Contractures, also
usually referred as to “muscle shortening” or “retractions”
among sport practitioners, are a common injury in elite road
cyclists, which show a high number of muscle “contractures”
caused by repetitive eccentric and concentric exercise.[4] The
incidence of these lesions deserves more attention and should be
included in sports injury surveillances.[4] Indeed contractures,
besides forcing athletes to suspend or limit training and
competitions, predispose to more severe muscle and tendon
lesions.[39] For example, in elite cycling, riders develop shortening
of some muscle groups due to maintained unphysiological
positions during cycling: such retractions might have important
clinical implications on spine–pelvic muscle imbalance. Hence,
any strategy to prevent or reduce the onset of muscle contractures
developing in the course of similar stressing situation would
deserve greater attention.
A ﬁnal but not trivial remark is that although we did not
speciﬁcally address this end-point, TCC does not seem to affect or
limit athletes’ performance. This topic will be more thoroughly
investigated in future studies. In conclusion, the present study
demonstrates that elite cyclists develop increased, time-related
tone, stiffness and soreness in BF and RF in the course of top-level
competitions, leading to a situation which is a potential threat to
their athletic conditions, and that topical TCC foam represents a
simple strategy to signiﬁcantly prevent and attenuate such muscle
conditions with the additional advantage of being safe and well
tolerated.
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